chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: pentacel was given subcutaneously with no reported adverse event; Initial information received on 02-Jul-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who experienced diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (vero)] was given subcutaneously with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose (dose 4) of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, Suspension for injection (lot number, expiry date, strength: unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunization) and pentacel was given subcutaneously with no reported adverse event (incorrect route of product administration) (latency: same day). Information regarding batch number and expiration date corresponding to the one at time of event occurrence was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Injection site reaction, Neuralgia
Clinical narrative: Patient states she started having nerve pain appear a couple of weeks after vaccine was given; from the injection site that goes to her back; that has never happened before
Age: 40.0
Sex: F
Vaccine: HEPAB
Symptoms: Headache, Nausea, Pruritus, Sleep disorder, Vomiting
Clinical narrative: A couple hours after vaccination  pt started to vomit. Also experiencing  nausea, headache, itchiness, and difficulty sleeping.
Age: 0.33
Sex: F
Vaccine: TDAP
Symptoms: Vaccination site erythema, Wrong product administered
Clinical narrative: The wrong vaccine was grabbed out of the fridge. Reddness was at the sight of the vaccination
Age: 54.0
Sex: F
Vaccine: HEPA
Symptoms: Wrong product administered
Clinical narrative: Patient came in to get her second Hep B vaccine and was given her second Hep A vaccine instead.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Extra dose administered
Clinical narrative: pt had completed the Meningococcal ACWY series and gave a third dose today 07/08/24. supervisor and patients' parents were notified.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, PNC20, TDAP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PCV 20 was administered, patient was not due to receive this vaccination at this time.
Age: 21.0
Sex: M
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received the first dose of HEPLISAV-B on 05/10/24. Instead of waiting for 28 days to receive the 2nd dose, patient was given the second dose of HEPLISAV-B on 05/20/2024.  Patient did not have any side effects or adverse reactions. Our pharmacy will contact patient to return to the pharmacy the 2nd dose again (28 days).
Age: 25.0
Sex: F
Vaccine: UNK
Symptoms: Night sweats
Clinical narrative: The adverse event is night sweats that started the first dose of the vaccine and continued to happen every menstrual period after. I have never had night sweats prior to taking the vaccine and nothing had changed in my day-to-day life. I know it has been a long time since I received the vaccine, but thought I should report it for data. I just had night sweats two days ago and was searching if anyone had any similar symptoms from the moderna vaccine.
Sex: F
Vaccine: MMR, PNC20
Symptoms: Erythema, Skin warm
Clinical narrative: Patient states noticed redness and warmth to left arm. Patient went to urgent care and was treated with prednisone.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Muscle spasms, Pain
Clinical narrative: Pt received vaccine and then went to shop he felt a back spasm in his back and returned to the pharmacy. We asked him to sit and he was in lots of pain. Called EMS and the pain went away about 10mins later. The fire dept walked him back to his car and he went home. Patient is ok and now at home
Age: 48.0
Sex: M
Vaccine: MENB
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse events. Corporate informed me that the vaccine should have never been given because the patient did not meet the requirements for being outside the recommended age.
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, MENB, RV5
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: None  wrong vaccination given for age Trumenba given to 4mth old.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Myalgia, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Sore throat, cough, muscle pain
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Bell's palsy, Eyelid ptosis, Facial paralysis, Lacrimation increased
Clinical narrative: Bell's Palsy; This serious case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 04-APR-2024, the patient received the 2nd dose of Shingrix (intramuscular, left deltoid). On 21-MAY-2024, 47 days after receiving Shingrix, the patient experienced bell's palsy (Verbatim: Bell's Palsy) (serious criteria GSK medically significant). The outcome of the bell's palsy was not resolved.   It was unknown if the reporter considered the bell's palsy to be related to Shingrix.     The company considered the bell's palsy to be unrelated to Shingrix.   Additional Information: GSK receipt date: 01-JUL-2024 The patient stated that 4 weeks after receiving her 2nd Shingrix vaccine she developed and was diagnosed with Bells Palsy.  The reporter consented to follow up.; Sender's Comments: Bell's palsy is an unlisted event which is considered unrelated to GSK vaccine Shingrix.
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Bell's palsy
Clinical narrative: Bell's Palsy; This serious case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 04-APR-2024, the patient received the 2nd dose of Shingrix (intramuscular, left deltoid). On 21-MAY-2024, 47 days after receiving Shingrix, the patient experienced bell's palsy (Verbatim: Bell's Palsy) (serious criteria GSK medically significant). The outcome of the bell's palsy was not resolved.   It was unknown if the reporter considered the bell's palsy to be related to Shingrix.     The company considered the bell's palsy to be unrelated to Shingrix.   Additional Information: GSK receipt date: 01-JUL-2024 The patient stated that 4 weeks after receiving her 2nd Shingrix vaccine she developed and was diagnosed with Bells Palsy.  The reporter consented to follow up.; Sender's Comments: Bell's palsy is an unlisted event which is considered unrelated to GSK vaccine Shingrix.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash
Clinical narrative: On 7/7/2024 patient sent an image via the EMR portal of a classic zoster rash in T11 dermatome with some satellite lesions in upper chest.
Sex: U
Vaccine: PNC15
Symptoms: Syringe issue, Underdose
Clinical narrative: No additional AE or PQC details available; she was administering VAXNEUVANCE to a patient the finger flange broke during administration; when she was administering VAXNEUVANCE to a patient the finger flange broke during administration.; She reports the patient did not receive the full dose of VAXNEUVANCE but reports the doctor said it was a reasonable amount and they are not going to revaccinate.; This spontaneous report was received from a Registered Nurse (R.N) concerning unspecified patient of unknown age and gender. The patient's pertinent concurrent conditions, medical history, historical drugs, drug allergies and concomitant medications were not reported.  On 18-JUN-2024, the patient was vaccinated with a dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) lot # Y002963, expiration date: 04-OCT-2026, 0.5 milliliter (route was not provided) for prophylaxis.    When R.N was administering pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) to the patient the finger flange broke during administration (syringe issue and poor-quality device used). She reported no injuries due to the breakage. She reported the patient did not receive the full dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) (accidental underdose) but reported the doctor said it was a reasonable amount and they are not going to revaccinate.  Nurse did not wish to provide any patient information related to this AE. Nurse did not provide consent for follow-up. No additional AE or PQC details available (no adverse event).
Sex: U
Vaccine: ANTH
Symptoms: Expired product administered
Clinical narrative: Given BioThrax vaccine that was expired for 2 days; This initial spontaneous case report was received on 27JUN2024 from nurse practitioner regarding patient (patient one) of unknown age and gender who had "given BioThrax vaccine that was expired for 2 days" (PT: Expired product administered). The BioThrax (anthrax vaccine adsorbed; lot number unknown) was administered for immunisation.  The patient's medical history, concomitant medications, or known allergies were not reported.  It was reported that a patient was given BioThrax vaccine that was expired for 2 days. It was refrigerated for 30 days and then given.  The outcome of the reported event was not applicable.   The action taken with the BioThrax with respect to the reported event was not applicable.  No additional information was reported.  Based on the available information in the source document, two individual case safety reports (24000092 and 24000093) were created and linked in the database as it was reported by same reporter.  Company comment: It was reported that a patient was given BioThrax vaccine that was expired for 2 days (expired product administered). It was refrigerated for 30 days and then given. Further information regarding event was limited. The causality for the event of expired product administered has been assessed as not related with BioThrax. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a patient was given BioThrax vaccine that was expired for 2 days (expired product administered). It was refrigerated for 30 days and then given. Further information regarding event was limited. The causality for the event of expired product administered has been assessed as not related with BioThrax. The case is considered non serious as per medical assessment. US-EMERGENT BIOSOLUTIONS-24000093:Linked case-same reporter
Sex: U
Vaccine: ANTH
Symptoms: Expired product administered
Clinical narrative: Given BioThrax vaccine that was expired for 2 days; This initial spontaneous case report was received on 27JUN2024 from nurse practitioner regarding patient (second patient) of unknown age and gender who had "given BioThrax vaccine that was expired for 2 days" (PT: Expired product administered). The BioThrax (anthrax vaccine adsorbed; lot number: unknown) was administered for immunisation.  The patient's medical history, concomitant medications, or known allergies were not reported.  It was reported that patient was given BioThrax vaccine that was expired for 2 days. The BioThrax vaccine was refrigerated for 30 days and then given.  The outcome of the reported event was not applicable.   The action taken with the BioThrax with respect to the reported event was not applicable.  No additional information was reported.  Based on the available information in the source document, two individual case safety reports (24000092 and 24000093) were created and linked in the database as it was reported by same reporter.  Company comment: It was reported that a patient was given BioThrax vaccine that was expired for 2 days (expired product administered). It was refrigerated for 30 days and then given. Further information regarding event was limited. The causality for the event of expired product administered has been assessed as not related with BioThrax. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a patient was given BioThrax vaccine that was expired for 2 days (expired product administered). It was refrigerated for 30 days and then given. Further information regarding event was limited. The causality for the event of expired product administered has been assessed as not related with BioThrax. The case is considered non serious as per medical assessment. US-EMERGENT BIOSOLUTIONS-24000092:Linked case-same reporter
Age: 53.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; she was diagnosed with shingles; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (first case at 12 years of age), ophthalmic herpes zoster (shingles in her eye), retinal detachment (Patient's lens detached as a result of the shingles) and eye operation (The patient had total 4 surgeries and had 2 eye surgeries in 2013).   On an unknown date, the patient received the 2nd dose of Shingrix. In FEB-2023, the patient received the 1st dose of Shingrix. In JUN-2023, less than 5 months after receiving Shingrix and between 3 and 5 months after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: she was diagnosed with shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     The company considered the vaccination failure to be related to Shingrix and Shingrix. It was unknown if the company considered the shingles to be related to Shingrix and Shingrix.   Additional Information: GSK receipt date: 28-JUN-2024 The patient stated that she had her first dose of Shingrix and in 2023 the second dose was administered sometime within 2-6 months following the first dose.   The consumer stated she was diagnosed with shingles (lack of effect) and she had a past medical history of shingles.  The shingles in her eye caused her retina to detach and the consumer has had 4 surgeries to try and repair retina and her lens detached as a result of the shingles.   Surgery to repair both detached retina and lens. The reporter consented to follow up. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which is considered related to GSK vaccine Shingrix (Dose I and Dose II).
Age: 49.0
Sex: F
Vaccine: RAB
Symptoms: Ear discomfort
Clinical narrative: Within 15 minutes of receiving the shot, my right ear clogged up out of the  blue. Nothing I do will unclog it or make it pop. I cannot hear from my right ear, as if I were underwater or in an airplane, but yawning doesn't help to clear it. It hurts
Age: 4.0
Sex: M
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: Larger than recommended dose to a pediatric patient; Larger than recommended dose to a pediatric patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of overdose in a 4-year-old male patient who received HAV (Havrix 1440 adult) (batch number T9TL9, expiry date 05-DEC-2025) for prophylaxis.   On 27-JUN-2024, the patient received the 1st dose of Havrix 1440 adult. On 27-JUN-2024, an unknown time after receiving Havrix 1440 adult, the patient experienced overdose (Verbatim: Larger than recommended dose to a pediatric patient) and adult product administered to child (Verbatim: Larger than recommended dose to a pediatric patient). The outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 27-JUN-2024 The healthcare professional was transferred over to the medical information team by another GlaxoSmithKline employee. The reporter was asked about any recommendation available for the usage of and adult dose in children of Havrix. The child patient received adult dose of Havrix vaccine, which led to overdose and adult product administered to child. The data was given and added to the report about the patient and vaccine. The vaccine administration facility was the same as primary reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient was given Shingrix vaccine reconstituted with unapproved diluent (sterile saline water); Patient was given Shingrix vaccine reconstituted with unapproved diluent (sterile saline water); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) (batch number 747N3, expiry date 15-JUN-2026) for prophylaxis.   On 27-JUN-2024, the patient received Shingrix. On 27-JUN-2024, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Patient was given Shingrix vaccine reconstituted with unapproved diluent (sterile saline water)) and inappropriate dose of vaccine administered (Verbatim: Patient was given Shingrix vaccine reconstituted with unapproved diluent (sterile saline water)). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 28-JUN-2024 A reporter reported that a patient was given Shingrix vaccine reconstituted with unapproved diluent (sterile saline water) which led to Inappropriate dose of vaccine administered and Wrong solution used in drug reconstitution.
Age: 0.33
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: she administered an expired dose to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-month-old female patient who received Hib (Hiberix) (batch number H43J7, expiry date 13-JUN-2024) for prophylaxis.   On 18-JUN-2024, the patient received Hiberix. On 18-JUN-2024, an unknown time after receiving Hiberix, the patient experienced expired vaccine used (Verbatim: she administered an expired dose to a patient). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 27-JUN-2024 and 28-JUN-2024 The reporter was a medical assistant. The reporter reported that she administered an expired dose to a patient, which led to expired vaccine used. This was the pediatric dose, lot number and detail from the patient was requested and provided from her end. The reporter asked if she had to readminister it or it was a valid dose. The vaccine administration facility was the same as primary reporter.
Age: 1.25
Sex: M
Vaccine: HIBV
Symptoms: No adverse event, Product preparation error, Product preparation issue
Clinical narrative: It was discovered that patient only received the diluent and not the actual vaccine Guardian hasn't reported any adverse reactions
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: Went to Hospital per nurse at clinic, child was given vaccines around 3:30 pm 6/7/2024 & left. No problems at this time. Client's mother brought child back to Health Dept. around 4:30 pm same day. Per the nurse reporting to me, child had hives all over his body, neck & face. 911 called - & she stated she did take child to hospital & per the mother, Dr. at ER stated was allergic reaction to one of the vaccines. Child released same day 6/7/2024 from ER.
Age: 1.0
Sex: M
Vaccine: MMRV, PNC20
Symptoms: Hypersensitivity, Pyrexia, Rash, Vomiting
Clinical narrative: Patient developed fever, vomiting and rash diffuse & global; (L) half body greater than (R) half but arms, legs, trunk, back & lower lip. Patient brought to local ED where Txed for "ALLERGIC reaction" with prednisone (4 day course), benadryl, ZOFRAN.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Malaise, Post-acute COVID-19 syndrome
Clinical narrative: After the second dose, within 24 hours I was ill. Then had long Covid for 18-months. This vaccine was mandated by my employer at the time as a requirement of continued employment.  Human Resources demonstrated ZERO concern for the affects of this mandated vaccine's adverse impact on my health.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema of eyelid, Feeling hot, Swelling of eyelid
Clinical narrative: Patient received the Tdap vaccine on Thursday 6/27 mid afternoon. She reported arriving home and within a couple of hours developing warmth (T max 99F) as well as eyelid redness and swelling. She took acetaminophen and des-loratadine with some relief. Symptoms continued over the next several days and were mild so she continued taking acetaminophen and des-loratadine. However, about 7 days after the vaccination day, the eyelid swelling worsened with significant  erythema and pruritus.  She never developed swelling anywhere else, no rashes, no respiratory distress, no vomiting. She was evaluated 7/8 in the same primary care office. At that time, she was prescribed prednisone and diphenhydramine for the eyelid edema. She had developed new myalgias and fatigue around 7/6, she tested positive for covid 7/8 with rapid antigen test.
Age: 41.0
Sex: F
Vaccine: UNK
Symptoms: Biopsy skin abnormal, Neurological symptom, Small fibre neuropathy
Clinical narrative: Small Fiber Neuropathy with symptoms of dysautonomia that started 2 weeks after her 2nd vaccination.
Age: 18.0
Sex: F
Vaccine: HEPA, MENB
Symptoms: No adverse event
Clinical narrative: Adult dose of HEP A vaccine administered to an 18 year, 9 months, and 24 days old person. No side effects or adverse reactions.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough infection
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Patient only received partial dose of Pentacel, patient received DTap & IPV and  did not receive the Hib
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Cold sweat, Dizziness, Gastrointestinal disorder, Injection site pain
Clinical narrative: No issues at administration. Injection site felt sore about 3 hours after injection. Patient states the next day they had one bout of GI issues, but no diarrhea. The morning after the vaccine, patient states they went from laying down to standing and immediately had to lay back down, felt as though they blacked out. Woke and drank a glass of water. Felt clammy. Issue resolved itself. States she does have low blood pressure issues. Notified pharmacy on 7/9/24.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal discomfort, Anaesthesia, Band sensation, Discomfort, Dizziness
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ejaculation disorder, Functional gastrointestinal disorder, Genital anaesthesia, Immunisation reaction, Immunosuppressant drug therapy
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Impaired work ability, Limb discomfort, Loss of proprioception, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Myelitis transverse, Nervous system injury, Neurosarcoidosis, Orgasmic sensation decreased, Pain of skin
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Paraesthesia, Sensory loss, Skin burning sensation, Spinal cord disorder, Spinal cord injury thoracic
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Symptom recurrence, Therapy non-responder
Clinical narrative: THIS VAERS E-REPORT IS BEING SUBMITTED ON 07/09/2024 TO REPORT THE ADDITIONAL NEUROLOGIC INJURIES CAUSED BY THE PFIZER COVID BOOSTER INJECTION.   The Pfizer Bivalent Covid Booster was administered to me on 02/14/2023, and on 02/18/2023 the tips of all my toes became simultaneously anesthetic.  This loss of skin sensation steadily ascended in a cephalad direction over the months of March, April, and May.  Additional studies were ordered by my PCM's office to rule out any possible medical conditions (all of which were negative) as well as Neurology consultation through Medical Center.  Consultation was scheduled for August 2023.  By June, my skin from the umbilicus to my toes were anesthetic and began to affect the genital and perianal regions.  At this time, I finally found a Neurology Clinic that accepted my insurance and was seen on 06/19/2023 and immediately admitted to Hospital and found to have multilevel T1-T7 transverse myelitis attributed to the Covid booster.  High-dose IV steroid immunosuppression was initiated inpatient for one week, followed by essentially a 9-month course of outpatient steroid taper ultimately ending in March 2024.  The anesthesia ultimately resolved, but every time a low dose of Prednisone taper was approached, unbearable burning skin pain arose for the nipples to the toes.  Finally, a trial of low-dose amitriptyline was started and abated the skin pain, finally permitting the cessation of the oral steroids.  The lower abdominal and lower extremity paresthesias have also persisted.  A new constant crushing pressure band syndrome then began to manifest across the lower half of the abdomen and flanks, circumferentially around the mid-thighs and mid-tibial regions, and across the dorsum of both feet.  No treatment has helped abate these extremely altered and unpleasant sensations.  No steroid medications were taken from March through early June of 2024, as symptoms continued to worsen.  A repeat MRI of the brain, cervical, thoracic and lumbar spinal cord was obtained on 05/27/2024 which revealed worsening of the previously identified thoracic spinal cord lesion, and for which my neurologist Dr. prompted urgent hospital readmission.
Age: 53.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Erythema, Limb mass, Pain, Pain in extremity
Clinical narrative: Patient got first dose of shingrix and her Adacel on 7/8/24. Patient call on the AM of 7/9 reporting some minor body aches to lower half, arm soreness with a knot as well as redness that began throughout the night.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient given Bexero instead of Trumemba. No treatment needed, no signs or symptoms
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Product preparation error, Underdose
Clinical narrative: Patient was given only the diluent of the product and not the powder-no issues
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Brain fog, Cough, Fatigue, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Fatigue, sore throat, brain fog, dry cough
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test, Neuropathy peripheral, Oedema peripheral, X-ray
Clinical narrative: Severe hand edema and neuropathy in hands presenting 3/10/24.  Osteoarthritis ruled out. Naproxen and gabapentin prescribed.  Patient is still experiencing symptoms.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Dysstasia, Exercise tolerance decreased, Gait disturbance
Clinical narrative: Two days after first shot.  Shortness of breath, elevated heart rate.  -I took my second dose of the Covid vaccine on September 10, 2021. After receiving a second dose I did not have an immediate reaction.  However I did experience a reaction days later, approximately 2 days. I began to experience the shortness of breath, tightness in my chest, and leg weakness.  The symptoms persisted throughout the week.  I was so concerned that I called my PCP on the 16th for an appointment. They could not get me in until the 21st. So..I spoke with a nurse working on the Covid floor at a local hospital, and a family nurse practitioner for recommendations on what I should do since my primary physician could not see me immediately.  I was told to monitor my O2 level, BP, and heart rate?and if things continued to decline to go to the ER.  Grateful, the symptoms decreased.  Went to the doctor on the 16th.  After speaking with my physician and explaining the symptoms that I was experiencing, he ran a blood panel. From there, and after may providing him with information he found it I had a slightly low level of vitamin D but nothing extreme. He prescribed vitamin D for eight weeks.  During such time I was physically unable to run, or jump, and occasionally had a hard time walking.  I was also experiencing numbness and tingling in my hands/wrists/forearms.  These issues initially presented in on in my right hand/wrist/forearm, but soon spread to my left as well.  With walking I found it extremely hard to walk inclines in parking lots, walk really fast, or stand for long periods of time. I also found it extremely hard to walk long distances.  Strange, I had this bumpy feeling on the bottom of my feet.  I purchased new shoes and those they may not be suitable for me, but this feeling was present no matter the shoes I wore.  I also had this strange feeling of my pinky toes not seeming as if they were touching the ground.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging, Migraine, Muscular weakness, Nerve conduction studies
Clinical narrative: Two days after first shot.  Shortness of breath, elevated heart rate.  -I took my second dose of the Covid vaccine on September 10, 2021. After receiving a second dose I did not have an immediate reaction.  However I did experience a reaction days later, approximately 2 days. I began to experience the shortness of breath, tightness in my chest, and leg weakness.  The symptoms persisted throughout the week.  I was so concerned that I called my PCP on the 16th for an appointment. They could not get me in until the 21st. So..I spoke with a nurse working on the Covid floor at a local hospital, and a family nurse practitioner for recommendations on what I should do since my primary physician could not see me immediately.  I was told to monitor my O2 level, BP, and heart rate?and if things continued to decline to go to the ER.  Grateful, the symptoms decreased.  Went to the doctor on the 16th.  After speaking with my physician and explaining the symptoms that I was experiencing, he ran a blood panel. From there, and after may providing him with information he found it I had a slightly low level of vitamin D but nothing extreme. He prescribed vitamin D for eight weeks.  During such time I was physically unable to run, or jump, and occasionally had a hard time walking.  I was also experiencing numbness and tingling in my hands/wrists/forearms.  These issues initially presented in on in my right hand/wrist/forearm, but soon spread to my left as well.  With walking I found it extremely hard to walk inclines in parking lots, walk really fast, or stand for long periods of time. I also found it extremely hard to walk long distances.  Strange, I had this bumpy feeling on the bottom of my feet.  I purchased new shoes and those they may not be suitable for me, but this feeling was present no matter the shoes I wore.  I also had this strange feeling of my pinky toes not seeming as if they were touching the ground.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Polyneuropathy, Sensory disturbance, Vitamin D decreased
Clinical narrative: Two days after first shot.  Shortness of breath, elevated heart rate.  -I took my second dose of the Covid vaccine on September 10, 2021. After receiving a second dose I did not have an immediate reaction.  However I did experience a reaction days later, approximately 2 days. I began to experience the shortness of breath, tightness in my chest, and leg weakness.  The symptoms persisted throughout the week.  I was so concerned that I called my PCP on the 16th for an appointment. They could not get me in until the 21st. So..I spoke with a nurse working on the Covid floor at a local hospital, and a family nurse practitioner for recommendations on what I should do since my primary physician could not see me immediately.  I was told to monitor my O2 level, BP, and heart rate?and if things continued to decline to go to the ER.  Grateful, the symptoms decreased.  Went to the doctor on the 16th.  After speaking with my physician and explaining the symptoms that I was experiencing, he ran a blood panel. From there, and after may providing him with information he found it I had a slightly low level of vitamin D but nothing extreme. He prescribed vitamin D for eight weeks.  During such time I was physically unable to run, or jump, and occasionally had a hard time walking.  I was also experiencing numbness and tingling in my hands/wrists/forearms.  These issues initially presented in on in my right hand/wrist/forearm, but soon spread to my left as well.  With walking I found it extremely hard to walk inclines in parking lots, walk really fast, or stand for long periods of time. I also found it extremely hard to walk long distances.  Strange, I had this bumpy feeling on the bottom of my feet.  I purchased new shoes and those they may not be suitable for me, but this feeling was present no matter the shoes I wore.  I also had this strange feeling of my pinky toes not seeming as if they were touching the ground.
Age: 55.0
Sex: F
Vaccine: RSV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: RSV vaccine given 5 years too early, age 55 instead of >60 years of age.  Patient contacted, no adverse outcome, no symptoms, no issues, and side effects.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC20, VARCEL
Symptoms: Dyspnoea, Erythema
Clinical narrative: After giving vaccines patient seemed as he is unable to take a deep breath. No audible wheezing heard.  Shirt removed to assess how patient is breathing and retractions noted at the bottom of patients ribs. Emergency switch activated and EMS called at 10:37am. Heart rate and O2 monitored until EMS arrival and noted to be O2 97%-99% and HR 128-156. Red spots also noted on chest and back that mom says she is unsure if he had those when he came in. EMS arrived and transported to PMH ER.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Decreased appetite, Fatigue, Hypogeusia
Clinical narrative: Covid 19 (twice), fatigue, flu like symptoms  loss of appetite, increased joint pain, low grade fever, decreased taste,
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Covid 19 (twice), fatigue, flu like symptoms  loss of appetite, increased joint pain, low grade fever, decreased taste,
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Persistent tinnitus that hasn't abated.
Age: 17.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Heplisav-B was given to patient instead of the 18 or less Hep B vaccine. per Dr., will proceed with testing for immune response in 2 months
Age: 18.0
Sex: M
Vaccine: TYP
Symptoms: Fall, Malaise, Vision blurred
Clinical narrative: fell down, blurry vision, generally unwell. EMS called, responded 10-15 minutes later, taken to hospital afterwards.
Age: 2.0
Sex: F
Vaccine: HEPA, HIBV, TDAP
Symptoms: Injection site swelling
Clinical narrative: Patient had injection on 7/3/24. Patient mother called stating that patient has swelling bilaterally, right arm worse than left, at the vaccine injection sites. Provider made aware; provider suggested continuing the use of cold compress as that was effective.
Age: 0.5
Sex: M
Vaccine: HIBV
Symptoms: Extra dose administered
Clinical narrative: Parent called and stated his child got an additional dose even though the program said the patient was due
Age: 1.67
Sex: M
Vaccine: IPV
Symptoms: Extra dose administered
Clinical narrative: Vaccine was not needed based on vaccine schedule and patients vaccine record.
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Arthritis, Burning sensation, Condition aggravated, Erythema
Clinical narrative: Patient states at the day of injection she experienced burning and a red circle a little larger than a quarter. The red circle has not gone away since her immunization, and also notes that her arthritis has flared since having the injection.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: inappropriate dose for age